Mounjaro®
Starting from £179.99/mo
Start journey Learn moreUK doctors and regulators have raised clear, specific concerns about weight loss injections — not to discourage their use, but to protect people from counterfeit products, unsupervised access, and inadequate aftercare. These are prescription-only medicines that require a proper clinical assessment before any prescriber can legally supply them. The warnings are worth understanding in full before you decide how to proceed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The concern is not that these medicines are dangerous in properly supervised hands. The NHS, NICE, and the MHRA have all recommended tirzepatide and semaglutide for weight management in eligible adults, and the NICE appraisal of tirzepatide (TA1026) concluded the evidence was strong enough to recommend NHS funding. What prompted the warnings was something different: a rapid rise in people obtaining these medicines through unregulated channels, with no clinical oversight at all.
The MHRA seized roughly 20 million doses of illegally traded weight loss medicines (around £45 million in street value) in 2025. An illicit manufacturing site producing fake tirzepatide pens was raided in Northampton in October of that year. Fake pens have been found to contain insulin rather than the labelled medicine, a substitution that can cause life-threatening hypoglycaemia. You can report any suspect seller directly through the MHRA's Yellow Card scheme, which handles both side-effect reports and intelligence on illegal supply.
The pattern the MHRA flagged is consistent: sellers offering these medicines without a prescription, often via social media, at prices well below the market rate, sometimes with discount codes attached. That combination is the red flag. A genuine private prescription always includes a clinical assessment, the bargain that skips it is not a bargain.
Most side effects from GLP-1 medicines are gastrointestinal: nausea, loose stools, constipation, reflux, and burping are the most commonly reported, and they tend to be worst in the first weeks of treatment or after a dose change. For the majority of people they settle. That part is well known.
What doctors are more concerned people understand is the smaller risk of serious effects. In January 2026 the MHRA issued a formal Drug Safety Update for GLP-1 medicines specifically highlighting acute pancreatitis. The signal it describes: severe stomach pain that reaches into the back, with or without vomiting, that does not ease on its own. That warrants same-day emergency assessment, not a wait-and-see approach. Gallbladder problems are another known association; symptoms (right-sided upper-abdominal pain, particularly after eating) also need prompt attention. Dehydration from prolonged vomiting or diarrhoea can put strain on the kidneys, so staying well hydrated during any GI episode matters more than usual.
None of this is to alarm. It is the kind of safety briefing every patient should receive at the point of prescription, from a clinician who knows their history. The concern doctors raise is about what happens when that conversation never takes place. If you want to understand what getting weight loss injections from a doctor properly involves, including how interactions with other medicines are handled, the NHS tirzepatide page covers common drug interactions clearly.
One of the more practical warnings coming from GPs and prescribers involves oral contraceptives. Tirzepatide slows gastric emptying, which can reduce how much of an oral contraceptive is absorbed in the early weeks of treatment and after each dose increase. The clinical advice, drawn from NHS guidance, is to add a non-oral method (condoms, for instance) for the first four weeks of tirzepatide treatment and for four weeks after every dose step up. This is not a theoretical concern; it is written into the prescribing guidance.
NHS England also advises that women taking HRT might consider transdermal formulations (patches or gels) rather than tablets while on tirzepatide, again because of absorption. And anyone on these medicines who is scheduled for surgery should tell their anaesthetist, gastric emptying changes affect anaesthetic risk. These are the kinds of practical details that a doctor prescribing weight loss injections should discuss proactively, not leave the patient to discover afterwards. You can also explore weight loss injections during the menopause if HRT interaction is a specific concern for you.
The broader point doctors are making is that these are not lifestyle supplements you can self-manage. The prescription process exists precisely to surface these interactions, and to make a plan before the problem arises.
This is the practical decision doctors want people to make well. When you look at any private provider of weight loss injections, a few checks will tell you quickly whether clinical safety is genuinely embedded or just described in the marketing copy. First, verify them on the GPhC pharmacy register, every legal online pharmacy dispensing prescription medicines has a premises registration number you can look up. Second, check that a named, qualified prescriber reviews your consultation, not an automated system. Third, confirm that the process includes weight verification and identity checks before dispensing, not just a self-reported form.
A note on price: one of the clearest warnings from the regulatory community is that medicines sold at prices far below the market rate are a risk indicator, not a saving. The context around cheap weight loss injection pricing is worth reading if cost is a factor in your decision. If you are looking for weight loss injections doctors near you, it is worth knowing that at nume our own clinical team reviews every consultation personally, the same day it is submitted, your answers go to a prescriber, not a queue. All the safety measures doctors recommend are built into the process: photo ID, live weight verification on video, GP notification in line with GPhC guidance, and aftercare available seven days a week.
The warnings from UK doctors are not a reason to avoid treatment. They are a checklist for choosing it safely. Reading about what doctor weight loss injections should involve can help you ask the right questions before you commit to any provider. If you are ready to take that step, you can check your eligibility with a free consultation and have your case reviewed by a clinician the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.